Home Sequential Compression Devices Global Market Report 2024

The home sequential compression devices market size has grown strongly in recent years. It will grow from $1.02 billion in 2023 to $1.09 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth observed in the historical period can be attributed to several factors, including an increase in diabetes incidence rates, a growing aging population, escalating healthcare expenses, post-surgical recovery needs, and a notable shift towards home healthcare services.

The home sequential compression devices market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The anticipated growth in the forecast period is expected to stem from various factors, notably the increasing global health consciousness, proactive government initiatives and policies, the widening of distribution channels, a preference among patients for non-invasive treatment options, and the continuous aging of the population. Key trends projected for this period encompass advancements in technology, a surging uptake of telemedicine, the emergence of personalized healthcare solutions, the prevalence of remote work practices, and the integration of smart devices into healthcare systems.

The escalating prevalence of diabetes is anticipated to drive the expansion of the home sequential compression device market in the foreseeable future. Diabetes, a chronic metabolic disorder characterized by elevated blood sugar levels stemming from insufficient insulin production or utilization, has witnessed a surge due to various factors such as unhealthy dietary habits, sedentary lifestyles, demographic aging, as well as psychological stress. Home sequential compression devices play a pivotal role in managing diabetes-related complications by enhancing circulation, mitigating the risk of ulcers and infections, and promoting overall limb health. Their appeal lies in the convenience they offer for regular usage sans the necessity for frequent visits to healthcare facilities. For instance, as of July 2021, the International Diabetes Federation reported that 537 million individuals aged 20 to 79 were living with diabetes globally, with projections indicating a rise to over 643 million by 2030 and 783 million by 2045, underscoring the driving force behind the growth trajectory of the home sequential compression device market.

Key players in the home sequential compression devices market are directing their efforts towards the development of innovative products such as sequential compression devices and compression garments to maintain a competitive edge. Sequential compression devices (SCDs) serve as an effective method for preventing deep vein thrombosis (DVT) by enhancing blood flow in the legs, while compression garments target various areas including the lower legs, back, abdomen, pelvic, and hip regions, particularly beneficial for patients with lymphedema. For instance, in September 2023, AIROS Medical Inc., a US-based medical equipment manufacturer, introduced the AIROS 6P and compression pants, offering versatility with its compatibility across different voltage specifications worldwide. These advancements cater to the evolving needs of lymphedema patients, with the lower truncal pants garments addressing swelling in additional areas such as the legs and abdomen.

In June 2021, InfuSystem Holdings, Inc., a US-based provider of external ambulatory infusion pump services, forged a strategic partnership with Bio Compression Systems, Inc., a US-based manufacturer of pneumatic compression therapy equipment. The collaboration aims to enrich InfuSystem's integrated therapy service (ITS) platform by integrating lymphedema therapy as a new offering. Bio Compression Systems Inc.'s expertise lies in delivering devices for lymphedema and chronic venous insufficiency, further bolstering the comprehensive solutions portfolio offered by InfuSystem Holdings, Inc.

Major companies operating in the home sequential compression devices market are Cardinal Health Inc., Medtronic plc, Essity Health & Medical, DJO LLC, Arjo Medical Devices, BTL Corporate, Tactile Medical, Amoena Medical, Performance Health Supply Inc, Sigvaris Group, Huntleigh Healthcare Limited, Breg Inc, NormaTec, Abigo Medical AB, Medcom Group, BIOCOMPRESSION SYSTEMS, Precision Medical Products, Devon Medical Inc., AIROS Medical Inc., Mego Afek ltd., Remark Medical Services.

North America was the largest region in the home sequential compression devices market in 2023. The regions covered in the home sequential compression devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the home sequential compression devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Home sequential compression devices are medical apparatuses utilized in domestic settings to administer therapeutic compression to limbs. Leveraging pneumatic technology, these devices deliver intermittent pressure, enhancing circulation and addressing conditions such as lymphedema and venous insufficiency.

The primary categories of home sequential compression devices exist such as standard and portable. Standard variants, typically larger, are suitable for clinical or home use, delivering effective compression therapy for conditions such as lymphedema, thereby fostering better patient outcomes. These encompass various device types, including simultaneous sequential compression devices (SSCD) and alternate sequential compression devices (ASCD), catering to diverse applications such as deep vein thrombosis (DVT), lymphedema management, and chronic venous insufficiency (CVI).

The home sequential compression devices market research report is one of a series of new reports that provides home sequential compression devices market statistics, including the home sequential compression devices industry global market size, regional shares, competitors with home sequential compression devices market share, detailed home sequential compression devices market segments, market trends, and opportunities, and any further data you may need to thrive in the home sequential compression devices industry. This home sequential compression devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The home sequential compression devices market consists of sales of compression pump, compression garments, leg compression sleeves and power adapter. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.